Efficacy of acupoint catgut embedding therapy for phlegm-turbidity and blood-stasis metabolic dysfunction-associated fatty liver disease

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Dec 27, 2025; 17(12): 112063
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112063

Table 2 Clinical efficacy comparison, n (%)

ACET: Acupoint catgut embedding therapy.

Citation: Hu QH, Liu W, Yin HQ, Wang YF, Zhang WK, Shen ML. Efficacy of acupoint catgut embedding therapy for phlegm-turbidity and blood-stasis metabolic dysfunction-associated fatty liver disease. World J Gastrointest Surg 2025; 17(12): 112063
URL: https://www.wjgnet.com/1948-9366/full/v17/i12/112063.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.112063

Hu QH, Liu W, Yin HQ, Wang YF, Zhang WK, Shen ML. Efficacy of acupoint catgut embedding therapy for phlegm-turbidity and blood-stasis metabolic dysfunction-associated fatty liver disease. World J Gastrointest Surg 2025; 17(12): 112063 [PMID: 41479726 DOI: 10.4240/wjgs.v17.i12.112063]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.